Womens Health

GLP-1 and Endometriosis: What Women Need to Know About This Emerging Connection

If you're living with endometriosis, you know it's more than just painful periods. It's a complex condition that affects your entire body, from metabolism to inflammation to daily quality of life. Now, emerging research suggests that GLP-1 medications—originally developed for diabetes and weight management—might offer some unexpected benefits for women managing endometriosis. While we're still in the early stages of understanding this connection, what we're learning is genuinely promising.

Understanding the Endometriosis-Metabolism Connection

Endometriosis affects approximately 10% of women of reproductive age, but its impact goes far beyond the reproductive system. Recent studies have revealed that women with endometriosis often experience metabolic changes that can complicate their health picture.

Research shows that endometriosis is associated with increased insulin resistance, higher rates of metabolic syndrome, and chronic systemic inflammation. These aren't separate issues—they're interconnected problems that can make endometriosis symptoms worse while also affecting your overall metabolic health.

This is where GLP-1 medications enter the conversation. These drugs work on multiple pathways in your body, addressing not just blood sugar and weight, but also inflammation and metabolic function.

How GLP-1 Medications Work in Your Body

GLP-1 (glucagon-like peptide-1) medications like semaglutide and tirzepatide mimic a natural hormone your body produces after eating. They work by slowing digestion, reducing appetite, and improving how your body uses insulin.

But here's what makes them potentially relevant for endometriosis: GLP-1 receptors aren't just in your pancreas and digestive system. They're found throughout your body, including in areas involved in inflammation and immune response.

The Anti-Inflammatory Effect

One of the most exciting aspects of GLP-1 medications for endometriosis patients is their anti-inflammatory properties. Studies have shown that these medications can reduce systemic inflammation markers in the body.

Since endometriosis is fundamentally an inflammatory condition, this anti-inflammatory effect could potentially help reduce some of the pain and tissue damage associated with the disease. While we need more specific research on endometriosis patients, the broader anti-inflammatory effects are well-documented.

GLP-1 and Endometriosis-Related Weight Challenges

Many women with endometriosis struggle with weight management, and it's not your fault. The condition itself, combined with hormonal treatments, reduced mobility during painful episodes, and metabolic changes, can make maintaining a healthy weight incredibly difficult.

Excess weight can worsen endometriosis symptoms by increasing estrogen production (fat tissue produces estrogen) and promoting more inflammation. This creates a frustrating cycle that's hard to break.

GLP-1 medications can help interrupt this cycle by supporting meaningful weight loss, which in turn may help reduce estrogen levels and inflammation. Some women report that losing weight has helped reduce their endometriosis pain, though individual experiences vary widely.

The PCOS and Endometriosis Overlap

It's worth noting that some women have both PCOS (polycystic ovary syndrome) and endometriosis—a particularly challenging combination. These women often face even greater metabolic challenges, including significant insulin resistance.

GLP-1 medications are increasingly used to help manage PCOS-related metabolic issues, and for women dealing with both conditions, these medications might address multiple concerns simultaneously. They can improve insulin sensitivity, support weight management, and potentially reduce inflammation affecting both conditions.

What the Research Currently Shows

Let's be honest about where the science stands: we don't yet have large-scale studies specifically examining GLP-1 medications as a treatment for endometriosis. What we do have is promising preliminary data and a strong biological rationale.

Several smaller studies and case reports have noted improvements in pain and quality of life among women with endometriosis who were prescribed GLP-1 medications for metabolic reasons. Researchers have observed:

These observations are encouraging, but they're not the same as definitive proof. More research is definitely needed, and it's coming. Several research groups are now specifically investigating GLP-1 medications in endometriosis patients.

Important Considerations for Women With Endometriosis

If you're considering GLP-1 medication and have endometriosis, there are several factors to discuss with your healthcare provider.

Fertility Considerations

Many women with endometriosis are concerned about fertility. If you're planning to become pregnant, it's essential to know that GLP-1 medications should be stopped before conception. Current guidelines recommend discontinuing these medications at least two months before trying to conceive.

Interaction With Hormonal Treatments

Many endometriosis patients take hormonal medications to manage their condition. GLP-1 medications can slow stomach emptying, which might affect how your body absorbs oral hormonal treatments. Your doctor may need to monitor your response and possibly adjust timing or dosages.

Managing Side Effects

The most common side effects of GLP-1 medications—nausea, changes in bowel habits, and decreased appetite—can be particularly challenging if you already experience digestive issues related to endometriosis. Starting with a low dose and increasing gradually can help minimize these effects.

A Note on Gender and GLP-1 Research

While endometriosis specifically affects people with uteruses, it's worth noting that GLP-1 medications are prescribed to people of all genders for metabolic health. The anti-inflammatory and metabolic benefits these medications provide aren't gender-specific, though the particular application to endometriosis is obviously relevant to women and those assigned female at birth.

Much of the broader research on GLP-1 medications has historically underrepresented women, which is why the emerging focus on women's health conditions like endometriosis is so important and needed.

Is GLP-1 Right for Your Endometriosis Management Plan?

GLP-1 medications aren't a cure for endometriosis, and they shouldn't be viewed as a replacement for established endometriosis treatments. However, they might be a valuable addition to your management plan if you also have metabolic concerns like insulin resistance, prediabetes, type 2 diabetes, or weight-related health issues.

The decision to start GLP-1 medication should be made collaboratively with a healthcare provider who understands both your endometriosis and your metabolic health. The best outcomes happen when these medications are part of a comprehensive approach that may also include pain management, hormonal therapy, lifestyle modifications, and sometimes surgery.

From the Ozari Care Team

If you have endometriosis and are considering GLP-1 therapy, focus on your complete metabolic picture. We often see the best results when patients track not just weight, but also energy levels, pain patterns, and overall quality of life. This comprehensive approach helps us understand whether the medication is truly supporting your health goals beyond the number on the scale.

At Ozari Health we offer compounded Semaglutide and Tirzepatide as low as $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically Reviewed — Ozari Clinical Content Team (OCCT). Health writers and wellness professionals specializing in GLP-1 therapy, metabolic health, and weight loss medicine. Content reviewed in accordance with Ozari's Editorial Standards. Last reviewed: April 25, 2026.

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.

Last reviewed: April 25, 2026